These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 20577872

  • 1. Osteoporosis quality indicators using healthcare utilization data.
    Cadarette SM, Jaglal SB, Raman-Wilms L, Beaton DE, Paterson JM.
    Osteoporos Int; 2011 May; 22(5):1335-42. PubMed ID: 20577872
    [Abstract] [Full Text] [Related]

  • 2. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat.
    Ont Health Technol Assess Ser; 2006 May; 6(20):1-180. PubMed ID: 23074491
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Denosumab utilization among older adults in Ontario: patient characteristics, persistence with therapy, and return to therapy after an extended gap.
    Ban JK, Hao BB, McCarthy L, Guilcher SJT, Cadarette SM.
    Osteoporos Int; 2019 Sep; 30(9):1865-1872. PubMed ID: 31317248
    [Abstract] [Full Text] [Related]

  • 5. Rates of osteoporosis screening and treatment following vertebral fracture.
    Barton DW, Behrend CJ, Carmouche JJ.
    Spine J; 2019 Mar; 19(3):411-417. PubMed ID: 30142455
    [Abstract] [Full Text] [Related]

  • 6. Cost-effectiveness of fracture prevention in rural women with limited access to dual-energy X-ray absorptiometry.
    Ito K, Leslie WD.
    Osteoporos Int; 2015 Aug; 26(8):2111-9. PubMed ID: 25807913
    [Abstract] [Full Text] [Related]

  • 7. Vertebral fracture assessment by dual-energy X-ray absorptiometry along with bone mineral density in the evaluation of postmenopausal osteoporosis.
    Shetty S, John B, Mohan S, Paul TV.
    Arch Osteoporos; 2020 Feb 24; 15(1):25. PubMed ID: 32095943
    [Abstract] [Full Text] [Related]

  • 8. Cost and management of males with closed fractures.
    Brenneman SK, Yurgin N, Fan Y.
    Osteoporos Int; 2013 Mar 24; 24(3):825-33. PubMed ID: 22776864
    [Abstract] [Full Text] [Related]

  • 9. A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women.
    Yoshimura M, Moriwaki K, Noto S, Takiguchi T.
    Osteoporos Int; 2017 Feb 24; 28(2):643-652. PubMed ID: 27743068
    [Abstract] [Full Text] [Related]

  • 10. Osteoporosis pharmacotherapy following bone densitometry: importance of patient beliefs and understanding of DXA results.
    Brask-Lindemann D, Cadarette SM, Eskildsen P, Abrahamsen B.
    Osteoporos Int; 2011 May 24; 22(5):1493-501. PubMed ID: 20683704
    [Abstract] [Full Text] [Related]

  • 11. Compliance with osteoporosis treatment guidelines in postmenopausal women.
    Mountjoy CR, Shrader SP, Ragucci KR.
    Ann Pharmacother; 2009 Feb 24; 43(2):242-50. PubMed ID: 19196838
    [Abstract] [Full Text] [Related]

  • 12. Targeted assessment of fracture risk in women at midlife.
    Davis SR, Tan A, Bell RJ.
    Osteoporos Int; 2015 Jun 24; 26(6):1705-12. PubMed ID: 25630574
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of osteoporosis and fractures among women prescribed osteoporosis medication in five European countries: the POSSIBLE EU study.
    Roux C, Cooper C, Díez-Pérez A, Martinez L, Ortolani S, Gitlin M, Möller G, Shepherd S, Freemantle N.
    Osteoporos Int; 2011 Apr 24; 22(4):1227-36. PubMed ID: 20628731
    [Abstract] [Full Text] [Related]

  • 14. Intervals between bone mineral density testing with dual-energy X-ray absorptiometry scans in clinical practice.
    Lyu H, Yoshida K, Tedeschi SK, Zhao S, Xu C, Nigwekar SU, Leder BZ, Solomon DH.
    Osteoporos Int; 2019 Apr 24; 30(4):923-927. PubMed ID: 30680429
    [Abstract] [Full Text] [Related]

  • 15. US Preventative Services Task Force FRAX threshold has a low sensitivity to detect osteoporosis in women ages 50-64 years.
    Bansal S, Pecina JL, Merry SP, Kennel KA, Maxson J, Quigg S, Thacher TD.
    Osteoporos Int; 2015 Apr 24; 26(4):1429-33. PubMed ID: 25614141
    [Abstract] [Full Text] [Related]

  • 16. Use of antiosteoporotic medication in the Danish ROSE population-based screening study.
    Høiberg MP, Rubin KH, Holmberg T, Rothmann MJ, Möller S, Gram J, Bech M, Brixen K, Hermann AP.
    Osteoporos Int; 2019 Jun 24; 30(6):1223-1233. PubMed ID: 30911782
    [Abstract] [Full Text] [Related]

  • 17. Pulse-echo ultrasound method for detection of post-menopausal women with osteoporotic BMD.
    Karjalainen JP, Riekkinen O, Kröger H.
    Osteoporos Int; 2018 May 24; 29(5):1193-1199. PubMed ID: 29460101
    [Abstract] [Full Text] [Related]

  • 18. Post-fracture pharmacotherapy for women with osteoporotic fracture: analysis of a managed care population in the USA.
    Wilk A, Sajjan S, Modi A, Fan CP, Mavros P.
    Osteoporos Int; 2014 Dec 24; 25(12):2777-86. PubMed ID: 25112720
    [Abstract] [Full Text] [Related]

  • 19. Identifying postmenopausal women with osteoporosis by calcaneal ultrasound, metacarpal digital X-ray radiogrammetry and phalangeal radiographic absorptiometry: a comparative study.
    Boonen S, Nijs J, Borghs H, Peeters H, Vanderschueren D, Luyten FP.
    Osteoporos Int; 2005 Jan 24; 16(1):93-100. PubMed ID: 15197540
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.